Unknown

Dataset Information

Testing the amyloid cascade hypothesis: Prevention trials in autosomal dominant Alzheimer disease.


ABSTRACT:

Objective

The amyloid cascade hypothesis of Alzheimer disease (AD) has been increasingly challenged. Here, we aim to refocus the amyloid cascade hypothesis on its original premise that the accumulation of amyloid beta (Aβ) peptide is the primary and earliest event in AD pathogenesis as based on current evidence, initiating several pathological events and ultimately leading to AD dementia.

Background

An ongoing debate about the validity of the amyloid cascade hypothesis for AD has been triggered by clinical trials with investigational disease-modifying drugs targeting Aβ that have not demonstrated consistent clinically meaningful benefits.

Updated hypothesis

It is an open question if monotherapy targeting Aβ pathology could be markedly beneficial at a stage when the br

SUBMITTER: Levin J 

PROVIDER: S-EPMC9399299 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature